An Exploration of Ranibizumab Injection Frequency in Patients with Diabetic Macular Edema: A Post-hoc Analysis of the Restore and Retain Study

被引：0
|
作者：
Figueira, Joao [1 ]
Margaron, Philippe [2 ]
Hashmonay, Ron [2 ]
机构：
[1] AIBILI, Coimbra, Portugal
[2] Novartis Pharma AG, Basel, Switzerland
来源：
OPHTHALMOLOGICA | 2014年 / 232卷
关键词：
Diabetic Macular Edema; Ranibizumab; RESTORE Study; RETAIN Study; Visual Acuity;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
160
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [21] Pooled safety analysis in patients with visual impairment due to diabetic macular edema treated with 0.5 mg ranibizumab in RESOLVE and RESTORE trials
    Bandello, F.
    Lang, G. E.
    Schlingemann, R. O.
    Leclair, D.
    Weichselberger, A.
    DIABETOLOGIA, 2011, 54 : S454 - S454
  • [22] Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema. The BRDME study
    Vader, M. J. C.
    Schauwvlieghe, A. M. E.
    Verbraak, F. D.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Zwinderman, A. H.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    van Lith-Verhoeven, J. J. C.
    Dijkgraaf, M. G. W.
    Schlingemann, R. O.
    ACTA OPHTHALMOLOGICA, 2019, 97 : 40 - 40
  • [23] Vision-Threatening Complications in Patients with Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
    Gordon, Carmelina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [24] Predictors of As-Needed Ranibizumab Injection Frequency in Patients With Macular Edema Following Retinal Vein Occlusion
    Yiu, Glenn
    Huang, Denis
    Wang, Yinwen
    Wang, Zhe
    Yang, Ming
    Haskova, Zdenka
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 249 : 74 - 81
  • [25] Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Kiss, Szilard
    Malangone-Monaco, Elisabetta
    Wilson, Kathleen
    Varker, Helen
    Stetsovsky, Diana
    Smith, David
    Garmo, Vincent
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (03): : 253 - 266
  • [26] LONG-TERM SAFETY AND EFFICACY OUTCOME OF RANIBIZUMAB 0.5 MG IN PATIENTS WITH VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA: THE RESTORE EXTENSION STUDY
    Bailey, C.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2012, 22 (03) : 518 - 518
  • [27] Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study
    Vader, M. J. C.
    Verbraak, F. D.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    van Lith-Verhoeven, J. J. C.
    Schlingemann, R. O.
    Dijkgraaf, M. G. W.
    ACTA OPHTHALMOLOGICA, 2020, 98 : 42 - 42
  • [28] Evaluation of diabetic macular edema by using optical coherence tomography in patients underwent combined phacoemulsification and intravitreal ranibizumab injection versus patients underwent sequential intravitreal ranibizumab injection and phacoemulsification: an observational study
    El-Behaidy, Mohamed
    Mohamed, Ezz Eldein
    Dabour, Sherif
    Al-Naimy, Mohammed
    Elhiny, Rasha
    JOURNAL OF THE EGYPTIAN OPHTHALMOLOGICAL SOCIETY, 2023, 116 (03) : 188 - 192
  • [29] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Sonja G. Karst
    Jan Lammer
    Christoph Mitsch
    Manuela Schober
    Janhvi Mehta
    Christoph Scholda
    Michael Kundi
    Katharina Kriechbaum
    Ursula Schmidt-Erfurth
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 49 - 58
  • [30] Aqueous vascular endothelial growth factor before and after intravitreal injection of bevacizumab or ranibizumab in patients with diabetic macular edema
    Sawada, Osamu
    Fujikawa, Masato
    Ito, Yuka
    Sawada, Tomoko
    Ohji, Masahito
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345